Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.

[1]  Mark A Hlatky,et al.  Medical Costs and Quality of Life 10 to 12 Years After Randomization to Angioplasty or Bypass Surgery for Multivessel Coronary Artery Disease , 2004, Circulation.

[2]  Lisa Hartling,et al.  Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure , 2004, Annals of Internal Medicine.

[3]  Graham Nichol,et al.  Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure , 2004, Annals of Internal Medicine.

[4]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[5]  J. Cleland,et al.  Therapeutic Options and Cost Considerations in the Treatment of Ischemic Heart Disease , 1998, Cardiovascular Drugs and Therapy.

[6]  G. L’italien,et al.  The expanding national burden of heart failure in the United States: the influence of heart failure in women. , 2004, American heart journal.

[7]  E. Foster,et al.  Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. , 2003, Journal of the American College of Cardiology.

[8]  D. Delurgio,et al.  Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure , 2003, Circulation.

[9]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[10]  Peter Søgaard,et al.  Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. , 2002, Journal of the American College of Cardiology.

[11]  D. Mark,et al.  Medical economics and the assessment of value in cardiovascular medicine: Part I. , 2002, Circulation.

[12]  Thomas Lavergne,et al.  Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. , 2002, Journal of the American College of Cardiology.

[13]  Stefan Sack,et al.  Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. , 2002, Journal of the American College of Cardiology.

[14]  Erez Nevo,et al.  Quantitation of basal dyssynchrony and acute resynchronization from left or biventricular pacing by novel echo-contrast variability imaging. , 2002, Journal of the American College of Cardiology.

[15]  K. Seidl,et al.  Biventricular Pacing in Patients with ICD: How Many Patients are Possible Candidates? , 2002, The Thoracic and cardiovascular surgeon.

[16]  E. Foster,et al.  Effects of Long-Term Biventricular Stimulation for Resynchronization on Echocardiographic Measures of Remodeling , 2002, Circulation.

[17]  Luigi Tavazzi,et al.  Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. , 2002, American heart journal.

[18]  Won Yong Kim,et al.  Impact of Acute Biventricular Pacing on Left Ventricular Performance and Volumes in Patients with Severe Heart Failure , 2001, Cardiology.

[19]  G. Boriani,et al.  Cost-effectiveness of implantable cardioverter-defibrillators. , 2001, European heart journal.

[20]  Gregory S. Nelson,et al.  Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block , 2000, Circulation.

[21]  Tammy O. Tengs,et al.  One thousand health-related quality-of-life estimates. , 2000, Medical care.

[22]  M. Stanton,et al.  Economic outcomes of implantable cardioverter-defibrillators. , 2000, Circulation.

[23]  H. Calkins,et al.  Cost-effectiveness of catheter ablation in patients with ventricular tachycardia. , 2000, Circulation.

[24]  S. Anker,et al.  Intraventricular conduction delay: a prognostic marker in chronic heart failure. , 1999, International journal of cardiology.

[25]  W. Abraham,et al.  Patient preferences for heart failure treatment: utilities are valid measures of health-related quality of life in heart failure. , 1999, Journal of cardiac failure.

[26]  A I Mushlin,et al.  The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. , 1998, Circulation.

[27]  Erry,et al.  Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. , 1995, The New England journal of medicine.

[28]  J R Beck,et al.  Markov Models in Medical Decision Making , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[29]  R. Klein,et al.  The Beaver Dam Health Outcomes study , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.